Stockreport

Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Netherton Syndrome Combination Product [Yahoo! Finance]

Quoin Pharmaceuticals, Ltd. - American Depositary Shares  (QNRX) 
PDF company exclusively focused on the development and commercialization of innovative therapies that treat rare and orphan diseases, today announced it has filed U.S. and I [Read more]